Skip to main content
PMC home page
The Journal of General Physiology logoLink to The Journal of General Physiology
. 1968 Sep 1;52(3):465–481. doi: 10.1085/jgp.52.3.465

A Sensitive Hydroosmotic Toad Bladder Assay

Affinity and intrinsic activity of neurohypophyseal peptides

Patrick Eggena 1, Irving L Schwartz 1, Roderich Walter 1
PMCID: PMC2225828  PMID: 5691711

Abstract

A sensitive and precise method for assaying the water permeability response evoked by neurohypophyseal hormones and their synthetic analogues on the isolated urinary bladder of the toad (Bufo marinus L.) is described. The method permits detection of 8-arginine-vasotocin at concentrations as low as 10-12 M. This sensitivity, not achieved heretofore with this tissue, results largely from minimizing interference of inhibitory substances by means of an "in vitro circulation assembly." The precision of the method derives from a direct comparison between the cumulative dose-response curve of an agonist of unknown potency acting on one hemibladder and that of a reference compound acting on the contralateral hemibladder. Crystalline deamino-oxytocin is used as the reference standard in this assay. The intrinsic activity of 2-(O-methyltyrosine)-oxytocin, as defined by the maximal response, is 12% lower than that of deamino-oxytocin. All other hormonal peptides investigated have the same intrinsic activity as deamino-oxytocin, even 5-valine-oxytocin, in spite of its extremely low affinity. A comparison of the potencies of 8-arginine-vasotocin vs. 8-arginine-vasopressin, 8-ornithine-vasotocin vs. 8-ornithine-vasopressin, 8-alanine-oxytocin vs. 8-alanine-oxypressin, and deamino-8-alanine-oxytocin vs. deamino-8-alanine-oxypressin suggests that an isoleucine residue in position 3 imparts a higher specificity for binding of the hormonal peptide molecule to the bladder receptor than a phenylalanine residue in this locus.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acher R. Evolutionary aspects of the structure of proteins. Angew Chem Int Ed Engl. 1966 Sep;5(9):798–806. doi: 10.1002/anie.196607981. [DOI] [PubMed] [Google Scholar]
  2. BENTLEY P. J. The effects of neurohypophysial extracts on the water transfer across the wall of the isolated urinary bladder of the toad Bufo marinus. J Endocrinol. 1958 Sep;17(3):201–209. doi: 10.1677/joe.0.0170201. [DOI] [PubMed] [Google Scholar]
  3. CHAN W. Y., DU VIGNEAUD V. Comparison of the pharmacologic properties of oxytocin and its highly potent analogue, desamino-oxytocin. Endocrinology. 1962 Dec;71:977–982. doi: 10.1210/endo-71-6-977. [DOI] [PubMed] [Google Scholar]
  4. EDELMAN I. S., PETERSEN M. J., GULYASSY P. F. KINETIC ANALYSIS OF THE ANTIDIURETIC ACTION OF VASOPRESSIN AND ADENOSINE-3',5'-MONOPHOSPHATE. J Clin Invest. 1964 Nov;43:2185–2194. doi: 10.1172/JCI105092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eggena P., Walter R., Schwartz I. L. Relationship between hydro-osmotic flow and the inhibited response of the toad bladder to vasopressin. Life Sci. 1968 Jan 1;7(1):59–63. doi: 10.1016/0024-3205(68)90361-5. [DOI] [PubMed] [Google Scholar]
  6. Gulyassy P. F., Edelman I. S. Hydrogen-ion dependence of the antidiuretic action of vasopressin, oxytocin and deaminooxytocin. Biochim Biophys Acta. 1965 May 25;102(1):185–197. doi: 10.1016/0926-6585(65)90212-8. [DOI] [PubMed] [Google Scholar]
  7. HOPE D. B., MURTI V. V., DU VIGNEAUD V. A highly potent analogue of oxytocin, desamino-oxytocin. J Biol Chem. 1962 May;237:1563–1566. [PubMed] [Google Scholar]
  8. JARD S., MOREL F. Actions of vasotocin and some of its analogues on salt and water excretion by the frog. Am J Physiol. 1962 Feb;204:222–226. doi: 10.1152/ajplegacy.1963.204.2.222. [DOI] [PubMed] [Google Scholar]
  9. JARD S., MOREL F. [Competitive inhibition of the antidiuretic action of lysine-vasotocin by oxytocin in Rana esculenta]. C R Hebd Seances Acad Sci. 1961 Jan 9;252:339–341. [PubMed] [Google Scholar]
  10. JARVIS D., DUVIGNEAUD V. CRYSTALLINE DEAMINO-OXYTOCIN. Science. 1964 Feb 7;143(3606):545–548. doi: 10.1126/science.143.3606.545. [DOI] [PubMed] [Google Scholar]
  11. Karlin A., Overweg N. I. An inhibitor of oxytocin from the urinary bladder of the toad, Bufo marinus. Nature. 1965 Sep 25;207(5004):1401–1402. doi: 10.1038/2071401b0. [DOI] [PubMed] [Google Scholar]
  12. ORLOFF J., HANDLER J. S. The similarity of effects of vasopressin, adenosine-3',5'-phosphate (cyclic AMP) and theophylline on the toad bladder. J Clin Invest. 1962 Apr;41:702–709. doi: 10.1172/JCI104528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. RASMUSSEN H., SCHWARTZ I. L., YOUNG R., MARC-AURELE J. STRUCTURAL REQUIREMENTS FOR THE ACTION OF NEUROHYPOPHYSEAL HORMONES UPON THE ISOLATED AMPHIBIAN URINARY BLADDER. J Gen Physiol. 1963 Jul;46:1171–1189. doi: 10.1085/jgp.46.6.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schwartz I. L., Walter R. Factors influencing the reactivity of the toad bladder to the hydro-osmotic action of vasopressin. Am J Med. 1967 May;42(5):769–776. doi: 10.1016/0002-9343(67)90094-0. [DOI] [PubMed] [Google Scholar]
  15. Walter R., Rudinger J., Schwartz I. L. Chemistry and structure-activity relations of the antidiuretic hormones. Am J Med. 1967 May;42(5):653–677. doi: 10.1016/0002-9343(67)90087-3. [DOI] [PubMed] [Google Scholar]
  16. Walter R., Schwartz I. L. 5-Valine-oxytocin and 1-deamino-5-valine-oxytocin. Syntheses and some pharmacological properties. J Biol Chem. 1966 Dec 10;241(23):5500–5503. [PubMed] [Google Scholar]

Articles from The Journal of General Physiology are provided here courtesy of The Rockefeller University Press

RESOURCES